Albuminuria: What can we expect from the determination of nonimmunoreactive albumin?

Current Hypertension Reports

Volumn 11, Issue 2, 2009, Pages 111-117

  Bakker, Stephan J L ^a   Gansevoort, Ron T ^a   Zeeuw, Dick ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ALBUMINURIA; DIABETIC NEPHROPATHY; FOCAL GLOMERULOSCLEROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCHEMISTRY; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROCHIP ELECTROPHORESIS; NEPHELOMETRY; PROGNOSIS; PROTEIN ANALYSIS; REVIEW; URINALYSIS; URINE LEVEL;

ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETIC NEPHROPATHIES; HUMANS; IMMUNOCHEMISTRY; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SERUM ALBUMIN;

EID: 62549089722     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0021-x     Document Type: Review

References (53)

1. Svendsen PA, Oxenboll B, Christiansen JS: Microalbuminuria in diabetic patients - a longitudinal study. Acta Endocrinol Suppl (Copenh) 1981, 242:53-54.
2. Parving HH, Oxenboll B, Svendsen PA, et al.: Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982, 100:550-555.
3. Viberti GC, Hill RD, Jarrett RJ, et al.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430-1432.
4. Mogensen CE,AChachati A, Christensen CK, et al.: Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985, 9:85-95.
5. Jarrett RJ, Viberti GC, Argyropoulos A, et al.: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984, 1:17-19.
6. Lambers Heerspink HJ, Brinkman JW, Bakker SJ, et al.: Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens 2006, 15:631-636.
7. American Diabetes Association: Standards of medical care in diabetes - 2008. Diabetes Care 2008, 31(Suppl 1):S12-S54.
8. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998, 21:1551-1559.
9. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988, 2:530-533.
10. Hillege HL, Fidler V, Diercks GF, et al.: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
11. Jager A, Kostense PJ, Ruhe HG, et al.: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999, 19:617-624.
12. Arnlov J, Evans JC, Meigs JB, et al.: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 2005, 112:969-975.
13. Wang TJ, Gona P, Larson MG, et al.: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631-2639.
14. Xu J, Knowler WC, Devereux RB, et al.: Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: The Strong Heart Study. Am J Kidney Dis 2007, 49:208-216.
15. Kiberd B: The chronic kidney diSease epidemic: stepping back and looking forward. J Am Soc Nephrol 2006, 17:2967-2973.
16. Brantsma AH, Bakker SJ, Hillege HL, et al.: Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: The importance of urinary albumin excretion. Nephrol Dial Transplant 2008, 23:3851-3858.
17. de Jong PE, Gansevoort RT: Fact or fiction of the epidemic of chronic kidney disease - let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 2008, 23:1092-1095.
18. de Jong PE, van der Velde M, Gansevoort RT, et al.: Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol 2008, 3:616-623.
19. Sviridov D, Drake SK, Hortin GL: Reactivity of urinary albumin (microalbumin) assays with fragmented or modified albumin. Clin Chem 2008, 54:61-68.
20. Kshirsagar B, Wilson B, Wiggins RC: Polymeric complexes and fragments of albumin in normal human plasma. Clin Chim Acta 1984, 143:265-273.
21. Wiggins RC, Kshrisagar B, Kelsch RC, et al.: Fragmentation and polymeric complexes of albumin in human urine. Clin Chim Acta 1985, 149:155-163.
22. McCurdy TR, Gataiance S, Eltringham-Smith LJ, et al.: A covalently linked recombinant albumin dimer is more rapidly cleared in vivo than are wild-type and mutant C34A albumin. J Lab Clin Med 2004, 143:115-124.
23. Aldini G, Regazzoni L, Orioli M, et al.: A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: A new tool for studying vascular carbonylation. J Mass Spectrom 2008, 43:1470-1481.
24. Musante L, Candiano G, Petretto A, et al.: Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 2007, 18:799-810.
25. Doman J, Fox J, Hardwicke J: Conditions for albumin dimerisation in hephrotic urines. Dependence on an ultrafilterable factor. Clin Chim Acta 1980, 108:201-210.
26. Birtwistle RJ, Hardwicke J: The role of urea in albumin dimerisation in nephrotic urines. Clin Chim Acta 1985, 151:41-48.
27. Heine G, Raida M, Forssmann WG: Mapping of peptides and protein fragments in human urine using liquid chromatography-mass spectrometry. J Chromatogr A 1997, 776:117-124.
28. Brinkman JW, Heerspink HL, de Zeeuw D, et al.: Urinary pH affects albumin concentrations after prolonged frozen storage. Nephrol Dial Transplant 2007, 22:3670
29. Brinkman JW, de Zeeuw D, Duker JJ, et al.: Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin Chem 2005, 51:2181-2183.
30. Brinkman JW, de Zeeuw D, Lambers Heerspink HJ, et al.: Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. Clin Chem 2007, 53:1520-1526.
31. Osicka TM, Comper WD: Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004, 50:2286-2291.
32. Clavant SP, Sastra SA, Osicka TM, et al.: The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006, 39:143-151.
33. Brinkman JW, Bakker SJ, Gansevoort RT, et al.: Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int Suppl 2004, S69-S75.
34. Owen WE, Roberts WL: Performance characteristics of an HPLC assay for urinary albumin. Am J Clin Pathol 2005, 124:219-225.
35. Contois JH, Hartigan C, Rao LV, et al.: Analytical validation of an HPLC assay for urinary albumin. Clin Chim Acta 2006, 367:150-155.
36. Osicka TM, Hankin AR, Comper WD: Puromycin aminonucleoside nephrosis results in a marked increase in fractional clearance of albumin. Am J Physiol 1999, 277:F139-F145.
37. Burne MJ, Osicka TM, Comper WD: Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method. Kidney Int 1999, 55:261-270.
38. Osicka TM, Comper WD: Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Clin Sci (Lond) 1997, 93:65-72.
39. Sviridov D, Meilinger B, Drake SK, et al.: Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin. Clin Chem 2006, 52:389-397.
40. Doyen N, Lapresle C, Lafaye P, et al.: Study of the antigenic structure of human serum albumin with monoclonal antibodies. Mol Immunol 1985, 22:1-10.
41. Lapresle C, Webb T: Isolation and study of a fragment of human serum albumin containing one of the antigenic sites of the whole molecule. Biochem J 1965, 95:245-251.
42. Oettl K, Stauber RE: Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007, 151:580-590.
43. Chan OT, Herold DA: Chip electrophoresis as a method for quantifying total microalbuminuria. Clin Chem 2006, 52:2141-2146.
44. Shaikh A, Seegmiller JC, Borland TM, et al.: Comparison between immunoturbidimetry, size-exclusion chromatography, and LC-MS to quantify urinary albumin. Clin Chem 2008, 54:1504-1510.
45. McQueen MJ, Gerstein HC, Pogue J, et al.: Reevaluation by high-performance liquid chromatography: Clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 2006, 48:889-896.
46. Osicka TM, Houlihan CA, Chan JG, et al.: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000, 49:1579-1584.
47. Comper WD, Osicka TM, Clark M, et al.: Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004, 65:1850-1855.
48. Magliano DJ, Polkinghorne KR, Barr EL, et al.: HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007, 18:3171-3176.
49. Wang Z, Hoy WE, Nicol JL, et al.: Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high-risk Aboriginal population. Am J Kidney Dis 2008, 52:672-682.
50. Cook NR: Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007, 115:928-935.
51. Cook NR: Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008, 54:17-23.
52. Zethelius B, Berglund L, Sundstrom J, et al.: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116.
53. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al.: Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004, 110:32-35.